Loading
Latest filing published 21 Feb 2017 for BIOX Corporation, €3,860.
Stanley William Leo Spavold discloses dealings in BIOX Corporation to SEDI. Over a trading history stretching from 12 September 2016 to 13 September 2016, the count stands at 2 filings.
No open-market sale appears; the market trades are 2 purchases worth €8,159. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2017, the count stands at 1 purchase and no sales.
On 21 February 2017 came the latest disclosure, an open-market purchase for €3,860 in BIOX Corporation. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations